Astera Labs (NASDAQ:ALAB) Stock Price Down 5.3% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) traded down 5.3% during mid-day trading on Thursday . The stock traded as low as $280.53 and last traded at $284.53. 3,187,307 shares were traded during trading, a decline of 40% from the average daily volume of 5,292,045 shares. The stock had previously closed at $300.54.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Barclays boosted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Evercore restated an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Susquehanna raised their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research report on Monday, August 17th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Down 5.3%

The firm has a 50-day moving average price of $321.34 and a 200 day moving average price of $258.86. The firm has a market capitalization of $49.36 billion, a PE ratio of 140.86 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the company earned $0.44 EPS. Astera Labs’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total transaction of $963,734.80. Following the completion of the transaction, the director directly owned 50,456 shares of the company’s stock, valued at $13,873,381.76. This represents a 6.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 592,244 shares of company stock valued at $209,729,973. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

A number of large investors have recently modified their holdings of ALAB. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter worth $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the 2nd quarter valued at about $25,000. Archer Investment Corp acquired a new stake in Astera Labs in the 2nd quarter valued at about $30,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the period. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.